<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: liquid nitrogen</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Advanced brain investigations can become better and cheaper</title>
   	 <description>(Medical Xpress)—An important method for brain research and diagnosis is magnetoencephalography (MEG). But the MEG systems are so expensive that not all EU countries have one today. A group of Swedish researchers are now showing that MEG can be performed with technology that is significantly cheaper than that which is used today – technology that can furthermore provide new knowledge about the brain.</description>
     <link>http://medicalxpress.com/news/2012-12-advanced-brain-cheaper.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Fri, 14 Dec 2012 09:39:22 EST</pubDate>
	 <guid isPermaLink="false">news274700345</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/advancedbrai.jpg" width="90" height="90" />
</item>
<item>
     <title>Delivering stem cells by post means more effective global treatment</title>
   	 <description>(Medical Xpress)—Findings from a new University of Reading study could lead to cheaper, wider and more effective stem cell research and treatment of disease.</description>
     <link>http://medicalxpress.com/news/2012-12-stem-cells-effective-global-treatment.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 12 Dec 2012 08:41:45 EST</pubDate>
	 <guid isPermaLink="false">news274523904</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/55-.jpg" width="90" height="90" />
</item>
<item>
     <title>Cost-effective, low-tech weapons in the fight against cervical cancer</title>
   	 <description>Vinegar, liquid nitrogen and mobile phones are among the weapons being used by medical researchers in the fight against cervical cancer in India.</description>
     <link>http://medicalxpress.com/news/2012-11-cost-effective-low-tech-weapons-cervical-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 26 Nov 2012 07:20:01 EST</pubDate>
	 <guid isPermaLink="false">news273136155</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/newweaponsin.jpg" width="90" height="90" />
</item>
<item>
     <title>Fertility preservation with cryopreservation of ovarian tissue: from experimental to mainstream</title>
   	 <description>Although the first successful preservation of fertility from the freezing, thawing and grafting of ovarian tissue was reported eight years ago,(1) the technique has remained experimental and confined to a few specialist centres. Now, with the announcement of a first pregnancy (and subsequent live birth) in Italy following the transplantation of ovarian tissue, there are indications that fertility preservation is moving into the mainstream of reproductive medicine and into a greater number of centres.(2)</description>
     <link>http://medicalxpress.com/news/2012-07-fertility-cryopreservation-ovarian-tissue-experimental.html</link>
	 <category>Obstetrics &amp; gynaecology</category>
	 <pubDate>Wed, 04 Jul 2012 03:35:02 EST</pubDate>
	 <guid isPermaLink="false">news260591695</guid>
	 
</item>
<item>
     <title>French firm blamed for Italy frozen embryo accident</title>
   	 <description> An Italian hospital director on Monday blamed French industrial gas giant Air Liquide for an accident in an assisted reproduction lab last week that destroyed 94 embryos frozen in liquid nitrogen.</description>
     <link>http://medicalxpress.com/news/2012-04-french-firm-blamed-italy-frozen.html</link>
	 <category>Other</category>
	 <pubDate>Mon, 02 Apr 2012 08:32:04 EST</pubDate>
	 <guid isPermaLink="false">news252574313</guid>
	 
</item>
<item>
     <title>New drug now available for actinic keratosis</title>
   	 <description>A new topical gel now available by prescription significantly decreases the amount of time needed to treat actinic keratosis, a skin condition that is a common precursor to skin cancer, according to a multi-center trial led by researchers at Mount Sinai School of Medicine. The gel, called ingenol mebutate, is applied to the skin for just a few days, making it quicker and even more effective as current therapies require weeks to months to apply. The Phase III study results of the trial are published in the March 15, 2012 issue of the The New England Journal of Medicine.</description>
     <link>http://medicalxpress.com/news/2012-03-drug-actinic-keratosis.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 14 Mar 2012 18:19:47 EST</pubDate>
	 <guid isPermaLink="false">news250967973</guid>
	 
</item>


</channel>
</rss>
